Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Evolving treatment options in NDMM: transplant-eligible and transplant-ineligible patients

In this video, Leo Rasche, MD, University of Würzburg, Würzburg, Germany, gives an overview of his presentation at this year’s meeting, which focused on the evolving treatment landscape in newly diagnosed multiple myeloma (NDMM). Dr Rasche highlights the complexity of myeloma treatment, and further discusses the current standard of care (SOC) in patients with transplant-eligible and transplant-ineligible disease in the frontline setting. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.